Simulations Plus PE Ratio 2010-2024 | SLP
Current and historical p/e ratio for Simulations Plus (SLP) from 2010 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Simulations Plus PE ratio as of May 17, 2024 is 74.93.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Simulations Plus PE Ratio Historical Data |
| Date |
Stock Price |
TTM Net EPS |
PE Ratio |
| 2024-05-17 |
50.95 |
|
96.13 |
| 2024-02-29 |
41.44 |
$0.53 |
78.20 |
| 2023-11-30 |
39.09 |
$0.53 |
73.75 |
| 2023-08-31 |
44.28 |
$0.49 |
90.37 |
| 2023-05-31 |
43.93 |
$0.51 |
86.14 |
| 2023-02-28 |
37.77 |
$0.51 |
74.05 |
| 2022-11-30 |
40.24 |
$0.52 |
77.38 |
| 2022-08-31 |
59.44 |
$0.61 |
97.45 |
| 2022-05-31 |
46.95 |
$0.57 |
82.37 |
| 2022-02-28 |
38.90 |
$0.55 |
70.74 |
| 2021-11-30 |
46.32 |
$0.49 |
94.54 |
| 2021-08-31 |
43.62 |
$0.46 |
94.83 |
| 2021-05-31 |
51.91 |
$0.56 |
92.69 |
| 2021-02-28 |
70.47 |
$0.54 |
130.51 |
| 2020-11-30 |
54.95 |
$0.51 |
107.75 |
| 2020-08-31 |
58.45 |
$0.50 |
116.89 |
| 2020-05-31 |
49.66 |
$0.50 |
99.32 |
| 2020-02-29 |
31.87 |
$0.50 |
63.73 |
| 2019-11-30 |
32.65 |
$0.50 |
65.30 |
| 2019-08-31 |
35.22 |
$0.48 |
73.37 |
| 2019-05-31 |
24.41 |
$0.44 |
55.47 |
| 2019-02-28 |
19.92 |
$0.41 |
48.57 |
| 2018-11-30 |
19.19 |
$0.48 |
39.97 |
| 2018-08-31 |
20.12 |
$0.49 |
41.07 |
| 2018-05-31 |
18.47 |
$0.48 |
38.48 |
| 2018-02-28 |
14.91 |
$0.47 |
31.72 |
| 2017-11-30 |
14.85 |
$0.36 |
41.26 |
| 2017-08-31 |
13.80 |
$0.31 |
44.52 |
| 2017-05-31 |
11.57 |
$0.36 |
32.15 |
| 2016-11-30 |
8.89 |
$0.31 |
28.66 |
| 2016-08-31 |
8.06 |
$0.29 |
27.79 |
| 2016-05-31 |
7.10 |
$0.27 |
26.29 |
| 2016-02-29 |
8.84 |
$0.27 |
32.74 |
| 2015-11-30 |
8.21 |
$0.26 |
31.57 |
| 2015-08-31 |
6.17 |
$0.23 |
26.83 |
| 2015-05-31 |
5.35 |
$0.21 |
25.49 |
| 2015-02-28 |
5.72 |
$0.18 |
31.79 |
| 2014-11-30 |
5.68 |
$0.17 |
33.40 |
| 2014-08-31 |
5.95 |
$0.18 |
33.08 |
| 2014-05-31 |
5.31 |
$0.19 |
27.93 |
| 2014-02-28 |
4.97 |
$0.17 |
29.22 |
| 2013-11-30 |
4.34 |
$0.18 |
24.10 |
| 2013-08-31 |
4.10 |
$0.18 |
22.78 |
| 2013-05-31 |
3.74 |
$0.18 |
20.79 |
| 2013-02-28 |
3.40 |
$0.19 |
17.90 |
| 2012-11-30 |
3.73 |
$0.18 |
20.72 |
| 2012-08-31 |
3.62 |
$0.19 |
19.03 |
| 2017-02-28 |
9.12 |
$0.23 |
39.65 |
| 2012-05-31 |
3.17 |
$0.17 |
18.66 |
| 2012-02-29 |
3.18 |
$0.19 |
16.72 |
| 2011-11-30 |
2.41 |
$0.20 |
12.05 |
| 2011-08-31 |
2.53 |
$0.17 |
14.87 |
| 2011-05-31 |
2.27 |
$0.18 |
12.61 |
| 2011-02-28 |
2.58 |
$0.15 |
17.17 |
| 2010-11-30 |
2.32 |
$0.13 |
17.86 |
| 2010-08-31 |
1.93 |
$0.13 |
14.81 |
| 2010-05-31 |
1.89 |
$0.12 |
15.72 |
| 2010-02-28 |
1.31 |
$0.11 |
11.88 |
| 2009-11-30 |
1.11 |
$0.09 |
12.28 |
| Sector |
Industry |
Market Cap |
Revenue |
| Computer and Technology |
Computer Software |
$1.018B |
$0.060B |
|
Simulations Plus, Inc., is a premier developer of groundbreaking drug discovery and development simulation software, which is licensed to and used in the conduct of drug research by major pharmaceutical and biotechnology companies worldwide. They have two other businesses, Words+, Inc. and FutureLab, which are based on its proprietary software technologies.
|
